Literature DB >> 24624324

Screening of the central nervous system in children with invasive pulmonary aspergillosis.

Emmi Broenen1, Annelies Mavinkurve-Groothuis1, Karin Kamphuis-van Ulzen2, Roger Brüggemann3, Paul Verweij4, Adilia Warris5.   

Abstract

The existing guidelines regarding the management of invasive pulmonary aspergillosis do not recommend screening of the extra-pulmonary sites. Due to the fact that the presence of central nervous system (CNS) aspergillosis will influence treatment decisions regarding which antifungal to use and the aimed target concentrations of azoles in plasma, to be informed about dissemination of the infection to the CNS is absolutely necessary. We demonstrate the need for a structured approach to screening of pediatric patients for CNS aspergillosis.

Entities:  

Keywords:  Aspergillosis; Central nervous system; Pediatrics; Screening; Therapeutic drug monitoring; Voriconazole

Year:  2014        PMID： 24624324      PMCID： PMC3950533          DOI： 10.1016/j.mmcr.2014.02.001

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN： 2211-7539


  21 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  Impact of therapeutic drug monitoring of voriconazole in a pediatric population.

Authors:  Roger J M Brüggemann; Jan W M van der Linden; Paul E Verweij; David M Burger; Adilia Warris
Journal:  Pediatr Infect Dis J       Date:  2011-06       Impact factor: 2.129

3.  Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Authors:  William J Steinbach; Kieren A Marr; Elias J Anaissie; Nkechi Azie; Shun-Ping Quan; Herwig-Ulf Meier-Kriesche; Senu Apewokin; David L Horn
Journal:  J Infect       Date:  2012-08-13       Impact factor: 6.072

4.  Aspergillosis in children with cancer: A 34-year experience.

Authors:  S Abbasi; J L Shenep; W T Hughes; P M Flynn
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 5.  Aspergillosis case-fatality rate: systematic review of the literature.

Authors:  S J Lin; J Schranz; S M Teutsch
Journal:  Clin Infect Dis       Date:  2001-01-26       Impact factor: 9.079

6.  Azole-resistant central nervous system aspergillosis.

Authors:  Jan W M van der Linden; Rogier R Jansen; Dorine Bresters; Caroline E Visser; Suzanne E Geerlings; Ed J Kuijper; Willem J G Melchers; Paul E Verweij
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

7.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 8.  Cerebral aspergillosis: tissue penetration is the key.

Authors:  S Schwartz; E Thiel
Journal:  Med Mycol       Date:  2009-02-28       Impact factor: 4.076

9.  Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.

Authors:  Susan J Howard; Dasa Cerar; Michael J Anderson; Ahmed Albarrag; Matthew C Fisher; Alessandro C Pasqualotto; Michel Laverdiere; Maiken C Arendrup; David S Perlin; David W Denning
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

10.  Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation.

Authors:  Thomas Lehrnbecher; Robert Phillips; Sarah Alexander; Frank Alvaro; Fabianne Carlesse; Brian Fisher; Hana Hakim; Maria Santolaya; Elio Castagnola; Bonnie L Davis; L Lee Dupuis; Faith Gibson; Andreas H Groll; Aditya Gaur; Ajay Gupta; Rejin Kebudi; Sérgio Petrilli; William J Steinbach; Milena Villarroel; Theoklis Zaoutis; Lillian Sung
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544
View more
  3 in total

Review 1.  Progress in the Diagnosis of Invasive Fungal Disease in Children.

Authors:  Adilia Warris; Thomas Lehrnbecher
Journal:  Curr Fungal Infect Rep       Date:  2017-05-02

2.  Nosocomial legionellosis and invasive aspergillosis in a child with T-lymphoblastic leukemia.

Authors:  Rhoikos Furtwängler; Uwe Schlotthauer; Barbara Gärtner; Norbert Graf; Arne Simon
Journal:  Int J Hyg Environ Health       Date:  2017-05-13       Impact factor: 5.840

Review 3.  Pediatric Invasive Aspergillosis.

Authors:  Rachel L Wattier; Lynn Ramirez-Avila
Journal:  J Fungi (Basel)       Date:  2016-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.